VIVAX vs. EW

In the year-to-date period, VIVAX achieves a 15.89% return, which is significantly higher than EW's -1.89% return. Over the past 10 years, VIVAX has underperformed EW with an annualized return of 9.75%, while EW has yielded a comparatively higher 13.26% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Vanguard Value Index Fund (VIVAX) and Edwards Lifesciences Corporation (EW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current VIVAX Sharpe Ratio is 1.75, which is higher than the EW Sharpe Ratio of 0.02. The chart below compares the historical Sharpe Ratios of VIVAX and EW, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

VIVAX's dividend yield for the trailing twelve months is around 1.63%, while EW has not paid dividends to shareholders.

The maximum VIVAX drawdown since its inception was -59.38%, which is greater than EW's maximum drawdown of -54.32%. Use the drawdown chart below to compare losses from any high point for VIVAX and EW. For additional features, visit the drawdowns tool.

The current volatility for Vanguard Value Index Fund (VIVAX) is 3.62%, while Edwards Lifesciences Corporation (EW) has a volatility of 8.13%. This indicates that VIVAX experiences smaller price fluctuations and is considered to be less risky than EW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.